Scientific Presentations

Listen and view the various scientific presentations captured during our events held throughout the years.


Advancing clinical SPECT/CT: Integrating routine use with theranostic growth | Symposium at SNMMI 2025

 2025-06-23

Toni Bamford, CNMT, ARRT (CT), NMTCB RS (Radiation Safety), NCT, PeaceHealth, Springfield, Oregon, USA

SNMMI 2025

PET amyloid imaging in clinical trials | Vendor Workshop at RSNA 2024

 2025-04-23

Jacob Dubroff, MD, PhD, associate professor of radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

​RSNA 2024

Amyloid PET in the diagnosis and management of patients with suspected Alzheimer disease | Vendor Workshop at RSNA 2024

 2025-04-23

Jana Ivanidze, MD, PhD, associate professor of radiology, Weill Cornell Medical College, New York, New York, USA

RSNA 2024

The exploration of ultra-low dose PET/CT and its implications for patient care | Vendor Workshop at RSNA 2024

 2025-04-23

Eliot Siegel, MD, medical director at United Theranostics, Minneapolis, Minnesota, USA

RSNA 2024

A powerful bond for cancer treatment: Incorporating molecular imaging with nuclear therapeutics | Vendor Workshop at RSNA 2024

 2025-04-03
Ryan Avery, MD, director of nuclear medicine, Northwestern Medicine, Chicago, Illinois, USA.
RSNA 2024

Biograph Trinion PET/CT Future-forward by design | Symposium at EANM 2024

 2024-10-20

Sebastian Fuerst, PhD, product manager, Siemens Healthineers, Molecular Imaging, Knoxville, Tennessee, USA

EANM 2024

Biograph Vision Quadra: A change agent for molecular imaging | Symposium at EANM 2024

 2024-10-20

Daniel McCool, PhD, head of nuclear medicine, Royal Free Hospital, London, United Kingdom

EANM 2024

Advanced solutions in molecular imaging: Peritherapeutic theranostics | Symposium at EANM 2024

 2024-10-20

Friederike Eilsberger, MD, senior physician, Department of Nuclear Medicine, University Hospital Marlburg, Marlburg, Germany

EANM 2024

NIST-traceable fast quantitative SPECT/CT imaging of Lu-177: Personalized radiopharmaceutical therapy with Symbia Pro.specta | Symposium at SNMMI 2024

 2024-06-11

Michael Morris, MD, MS, co-founder physician, United Theranostics, Glen Burnie, Maryland, USA

SNMMI 2024

Biograph Trinion PET/CT: First user experience | Symposium at SNMMI 2024

 2024-06-10

Betty Harrell, R.T.(R)(N)(ARRT), lead nuclear medicine technologist and Russell L. Roberts, Jr, MD, nuclear medicine physician, Rome Imaging Center, Rome, Georgia, USA

SNMMI 2024

Prostate cancer radiopharmaceutical therapy: Beyond the basic | Vendor Workshop at RSNA 2023

 2023-11-28

Joseph R. Osborne, MD, PhD, Chief, Molecular Imaging and Therapeutics, Professor of Radiology, Director of the Radiology Health Equity Lab at New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New. York, USA.

RSNA 2023

PSMA PET: Technical and clinical case review | Vendor Workshop at RSNA 2023

 2023-11-26

Nicholas Feinberg, MD, Assistant Professor of Radiology, University of Chicago Medicine, Chicago, Illinois, USA.

RSNA 2023

Timing is of the essence: Unlocking the potential of PET/CT imaging with time of flight

 2023-09-28

Dr. Ian Armstrong, Nuclear Medicine Consultant Physicist, Manchester University NHS Foundation Trust, United Kingdom.

Transitioning to next-generation SPECT/CT | Symposium at EANM 2023

 2023-09-10

Juho Kuukasjärvi, radiographer, and Joni Granlund, radiographer, Oulu University Hospital, Oulu, Finland

EANM 2023

The potential Impact of Total Body PET to Whole Person Research and Network Medicine

 2023-09-09

Discover how Prof. Dr. Marcus Hacker envisions the potential of Total Body PET for whole person research and its effects on network medicine. 

EANM 2023